1月30日，复旦大学上海医学院陆路研究员、孙蕾研究员、姜世勃教授团队合作在《细胞》（Cell）杂志以Research Article的形式，在线发表了题为“Early fusion intermediate of ACE2-using coronavirus spike acting as antiviral ...

Tofacitinib, approved to treat ulcerative colitis, reversed the increased ACE2 expression on lung, intestinal, and immune cells, thus reducing susceptibility to viral invasion." Janus kinase (JAK ...

Tofacitinib, approved to treat ulcerative colitis, reversed the increased ACE2 expression on lung, intestinal, and immune cells, thus reducing susceptibility to viral invasion." Janus kinase (JAK ...

A section through the retinal pigment epithelium layer from an infected ACE2-expressing mouse ... despite only two small regions of N-protein expression. Scale bars: 50 µm.